GSK, Vir Bio’s COVID-19 antibody treatment can reduce hospitalisation, deaths
They announced the results of the study, pending online publication, that demonstrates the efficacy of VIR-7831 against variants of concern from the UK, South Africa and Brazil. On the basis…